Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site

  • Authors:
    • Hiroki Otsuka
    • Hideo Sasai
    • Mina Nakama
    • Yuka Aoyama
    • Elsayed Abdelkreem
    • Hidenori Ohnishi
    • Vassiliki Konstantopoulou
    • Jörn Oliver Sass
    • Toshiyuki Fukao
  • View Affiliations

  • Published online on: October 10, 2016     https://doi.org/10.3892/mmr.2016.5819
  • Pages: 4906-4910
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Beta-ketothiolase deficiency, also known as mitochondrial acetoacetyl-CoA thiolase (T2) deficiency, is an autosomal recessive disease caused by mutations in the acetyl‑CoA acetyltransferase 1 (ACAT1) gene. A German T2‑deficient patient that developed a severe ketoacidotic episode at the age of 11 months, was revealed to be a compound heterozygote of a previously reported null mutation, c.472A>G (p.N158D) and a novel mutation, c.949G>A (p.D317N), in ACAT1. The c.949G>A mutation was suspected to cause aberrant splicing as it is located within an exonic splicing enhancer sequence (c. 947CTGACGC) that is a potential binding site for serine/arginine‑rich splicing factor 1. A mutation in this sequence, c.951C>T, results in exon 10 skipping. A minigene construct was synthesized that included exon 9‑truncated intron 9‑exon 10‑truncated intron 10‑exon 11, and the splicing of this minigene revealed that the c.949G>A mutant construct caused exon 10 skipping in a proportion of the transcripts. Furthermore, additional substitution of G for C at the first nucleotide of exon 10 (c.941G>C) abolished the effect of the c.949G>A mutation. Transient expression analysis of the c.949G>A mutant cDNA revealed no residual T2 activity in the mutated D317N enzyme. Therefore, c.949G>A (D317N) is a pathogenic missense mutation, and diminishes the effect of an exonic splicing enhancer and causes exon 10 skipping. The present study demonstrates that a missense mutation, or even a synonymous substitution, may disrupt enzyme function by interference with splicing.
View Figures
View References

Related Articles

Journal Cover

November-2016
Volume 14 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Otsuka H, Sasai H, Nakama M, Aoyama Y, Abdelkreem E, Ohnishi H, Konstantopoulou V, Sass JO and Fukao T: Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site. Mol Med Rep 14: 4906-4910, 2016
APA
Otsuka, H., Sasai, H., Nakama, M., Aoyama, Y., Abdelkreem, E., Ohnishi, H. ... Fukao, T. (2016). Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site. Molecular Medicine Reports, 14, 4906-4910. https://doi.org/10.3892/mmr.2016.5819
MLA
Otsuka, H., Sasai, H., Nakama, M., Aoyama, Y., Abdelkreem, E., Ohnishi, H., Konstantopoulou, V., Sass, J. O., Fukao, T."Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site". Molecular Medicine Reports 14.5 (2016): 4906-4910.
Chicago
Otsuka, H., Sasai, H., Nakama, M., Aoyama, Y., Abdelkreem, E., Ohnishi, H., Konstantopoulou, V., Sass, J. O., Fukao, T."Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site". Molecular Medicine Reports 14, no. 5 (2016): 4906-4910. https://doi.org/10.3892/mmr.2016.5819